Global Neurovascular Thrombectomy Device Market Insights, Forecast to 2028

Table Of Contents

1 Study Coverage

1.1 Neurovascular Thrombectomy Device Product Introduction 1.2 Market by Type 1.2.1 Global Neurovascular Thrombectomy Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Mechanical/Fragmentation Thrombectomy Devices 1.2.3 Stent Retrievers 1.2.4 Basket/Brush Retrievers 1.2.5 Coil Retrievers 1.2.6 Aspiration Thrombectomy Devices 1.2.7 Rheolytic/Hydrodynamic Thrombectomy Devices 1.2.8 Ultrasonic Thrombectomy Devices 1.3 Market by Application 1.3.1 Global Neurovascular Thrombectomy Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals and Surgical Centers 1.3.3 Ambulatory Surgical Centers 1.3.4 Research Laboratories & Academic Institutes 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered2 Executive Summary 2.1 Global Neurovascular Thrombectomy Device Sales Estimates and Forecasts 2017-2028 2.2 Global Neurovascular Thrombectomy Device Revenue Estimates and Forecasts 2017-2028 2.3 Global Neurovascular Thrombectomy Device Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Neurovascular Thrombectomy Device Sales by Region 2.4.1 Global Neurovascular Thrombectomy Device Sales by Region (2017-2022) 2.4.2 Global Sales Neurovascular Thrombectomy Device by Region (2023-2028) 2.5 Global Neurovascular Thrombectomy Device Revenue by Region 2.5.1 Global Neurovascular Thrombectomy Device Revenue by Region (2017-2022) 2.5.2 Global Neurovascular Thrombectomy Device Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa3 Competition by Manufacturers 3.1 Global Neurovascular Thrombectomy Device Sales by Manufacturers 3.1.1 Global Top Neurovascular Thrombectomy Device Manufacturers by Sales (2017-2022) 3.1.2 Global Neurovascular Thrombectomy Device Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neurovascular Thrombectomy Device in 2021 3.2 Global Neurovascular Thrombectomy Device Revenue by Manufacturers 3.2.1 Global Neurovascular Thrombectomy Device Revenue by Manufacturers (2017-2022) 3.2.2 Global Neurovascular Thrombectomy Device Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Neurovascular Thrombectomy Device Revenue in 2021 3.3 Global Neurovascular Thrombectomy Device Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Neurovascular Thrombectomy Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Neurovascular Thrombectomy Device Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans4 Market Size by Type 4.1 Global Neurovascular Thrombectomy Device Sales by Type 4.1.1 Global Neurovascular Thrombectomy Device Historical Sales by Type (2017-2022) 4.1.2 Global Neurovascular Thrombectomy Device Forecasted Sales by Type (2023-2028) 4.1.3 Global Neurovascular Thrombectomy Device Sales Market Share by Type (2017-2028) 4.2 Global Neurovascular Thrombectomy Device Revenue by Type 4.2.1 Global Neurovascular Thrombectomy Device Historical Revenue by Type (2017-2022) 4.2.2 Global Neurovascular Thrombectomy Device Forecasted Revenue by Type (2023-2028) 4.2.3 Global Neurovascular Thrombectomy Device Revenue Market Share by Type (2017-2028) 4.3 Global Neurovascular Thrombectomy Device Price by Type 4.3.1 Global Neurovascular Thrombectomy Device Price by Type (2017-2022) 4.3.2 Global Neurovascular Thrombectomy Device Price Forecast by Type (2023-2028)5 Market Size by Application 5.1 Global Neurovascular Thrombectomy Device Sales by Application 5.1.1 Global Neurovascular Thrombectomy Device Historical Sales by Application (2017-2022) 5.1.2 Global Neurovascular Thrombectomy Device Forecasted Sales by Application (2023-2028) 5.1.3 Global Neurovascular Thrombectomy Device Sales Market Share by Application (2017-2028) 5.2 Global Neurovascular Thrombectomy Device Revenue by Application 5.2.1 Global Neurovascular Thrombectomy Device Historical Revenue by Application (2017-2022) 5.2.2 Global Neurovascular Thrombectomy Device Forecasted Revenue by Application (2023-2028) 5.2.3 Global Neurovascular Thrombectomy Device Revenue Market Share by Application (2017-2028) 5.3 Global Neurovascular Thrombectomy Device Price by Application 5.3.1 Global Neurovascular Thrombectomy Device Price by Application (2017-2022) 5.3.2 Global Neurovascular Thrombectomy Device Price Forecast by Application (2023-2028)6 North America 6.1 North America Neurovascular Thrombectomy Device Market Size by Type 6.1.1 North America Neurovascular Thrombectomy Device Sales by Type (2017-2028) 6.1.2 North America Neurovascular Thrombectomy Device Revenue by Type (2017-2028) 6.2 North America Neurovascular Thrombectomy Device Market Size by Application 6.2.1 North America Neurovascular Thrombectomy Device Sales by Application (2017-2028) 6.2.2 North America Neurovascular Thrombectomy Device Revenue by Application (2017-2028) 6.3 North America Neurovascular Thrombectomy Device Market Size by Country 6.3.1 North America Neurovascular Thrombectomy Device Sales by Country (2017-2028) 6.3.2 North America Neurovascular Thrombectomy Device Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada7 Europe 7.1 Europe Neurovascular Thrombectomy Device Market Size by Type 7.1.1 Europe Neurovascular Thrombectomy Device Sales by Type (2017-2028) 7.1.2 Europe Neurovascular Thrombectomy Device Revenue by Type (2017-2028) 7.2 Europe Neurovascular Thrombectomy Device Market Size by Application 7.2.1 Europe Neurovascular Thrombectomy Device Sales by Application (2017-2028) 7.2.2 Europe Neurovascular Thrombectomy Device Revenue by Application (2017-2028) 7.3 Europe Neurovascular Thrombectomy Device Market Size by Country 7.3.1 Europe Neurovascular Thrombectomy Device Sales by Country (2017-2028) 7.3.2 Europe Neurovascular Thrombectomy Device Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia8 Asia Pacific 8.1 Asia Pacific Neurovascular Thrombectomy Device Market Size by Type 8.1.1 Asia Pacific Neurovascular Thrombectomy Device Sales by Type (2017-2028) 8.1.2 Asia Pacific Neurovascular Thrombectomy Device Revenue by Type (2017-2028) 8.2 Asia Pacific Neurovascular Thrombectomy Device Market Size by Application 8.2.1 Asia Pacific Neurovascular Thrombectomy Device Sales by Application (2017-2028) 8.2.2 Asia Pacific Neurovascular Thrombectomy Device Revenue by Application (2017-2028) 8.3 Asia Pacific Neurovascular Thrombectomy Device Market Size by Region 8.3.1 Asia Pacific Neurovascular Thrombectomy Device Sales by Region (2017-2028) 8.3.2 Asia Pacific Neurovascular Thrombectomy Device Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines9 Latin America 9.1 Latin America Neurovascular Thrombectomy Device Market Size by Type 9.1.1 Latin America Neurovascular Thrombectomy Device Sales by Type (2017-2028) 9.1.2 Latin America Neurovascular Thrombectomy Device Revenue by Type (2017-2028) 9.2 Latin America Neurovascular Thrombectomy Device Market Size by Application 9.2.1 Latin America Neurovascular Thrombectomy Device Sales by Application (2017-2028) 9.2.2 Latin America Neurovascular Thrombectomy Device Revenue by Application (2017-2028) 9.3 Latin America Neurovascular Thrombectomy Device Market Size by Country 9.3.1 Latin America Neurovascular Thrombectomy Device Sales by Country (2017-2028) 9.3.2 Latin America Neurovascular Thrombectomy Device Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina10 Middle East and Africa 10.1 Middle East and Africa Neurovascular Thrombectomy Device Market Size by Type 10.1.1 Middle East and Africa Neurovascular Thrombectomy Device Sales by Type (2017-2028) 10.1.2 Middle East and Africa Neurovascular Thrombectomy Device Revenue by Type (2017-2028) 10.2 Middle East and Africa Neurovascular Thrombectomy Device Market Size by Application 10.2.1 Middle East and Africa Neurovascular Thrombectomy Device Sales by Application (2017-2028) 10.2.2 Middle East and Africa Neurovascular Thrombectomy Device Revenue by Application (2017-2028) 10.3 Middle East and Africa Neurovascular Thrombectomy Device Market Size by Country 10.3.1 Middle East and Africa Neurovascular Thrombectomy Device Sales by Country (2017-2028) 10.3.2 Middle East and Africa Neurovascular Thrombectomy Device Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia11 Company Profiles 11.1 Stryker Corporation (U.S.) 11.1.1 Stryker Corporation (U.S.) Corporation Information 11.1.2 Stryker Corporation (U.S.) Overview 11.1.3 Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Stryker Corporation (U.S.) Recent Developments 11.2 Medtronic plc (Ireland) 11.2.1 Medtronic plc (Ireland) Corporation Information 11.2.2 Medtronic plc (Ireland) Overview 11.2.3 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Medtronic plc (Ireland) Recent Developments 11.3 Boston Scientific Corporation (U.S.) 11.3.1 Boston Scientific Corporation (U.S.) Corporation Information 11.3.2 Boston Scientific Corporation (U.S.) Overview 11.3.3 Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Boston Scientific Corporation (U.S.) Recent Developments 11.4 Johnson & Johnson (U.S.) 11.4.1 Johnson & Johnson (U.S.) Corporation Information 11.4.2 Johnson & Johnson (U.S.) Overview 11.4.3 Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Johnson & Johnson (U.S.) Recent Developments 11.5 Terumo Corporation (Japan) 11.5.1 Terumo Corporation (Japan) Corporation Information 11.5.2 Terumo Corporation (Japan) Overview 11.5.3 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Terumo Corporation (Japan) Recent Developments 11.6 Penumbra, Inc. (U.S.) 11.6.1 Penumbra, Inc. (U.S.) Corporation Information 11.6.2 Penumbra, Inc. (U.S.) Overview 11.6.3 Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Penumbra, Inc. (U.S.) Recent Developments 11.7 Spectranetics Corporation (U.S.) 11.7.1 Spectranetics Corporation (U.S.) Corporation Information 11.7.2 Spectranetics Corporation (U.S.) Overview 11.7.3 Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Spectranetics Corporation (U.S.) Recent Developments 11.8 Edwards Lifesciences Corporation (U.S.) 11.8.1 Edwards Lifesciences Corporation (U.S.) Corporation Information 11.8.2 Edwards Lifesciences Corporation (U.S.) Overview 11.8.3 Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Edwards Lifesciences Corporation (U.S.) Recent Developments 11.9 Argon Medical Devices, Inc. (U.S.) 11.9.1 Argon Medical Devices, Inc. (U.S.) Corporation Information 11.9.2 Argon Medical Devices, Inc. (U.S.) Overview 11.9.3 Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue and Gross Margin (2017-2022) 11.9.4 Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 Argon Medical Devices, Inc. (U.S.) Recent Developments 11.10 Teleflex Incorporated (U.S.) 11.10.1 Teleflex Incorporated (U.S.) Corporation Information 11.10.2 Teleflex Incorporated (U.S.) Overview 11.10.3 Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue and Gross Margin (2017-2022) 11.10.4 Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 Teleflex Incorporated (U.S.) Recent Developments12 Industry Chain and Sales Channels Analysis 12.1 Neurovascular Thrombectomy Device Industry Chain Analysis 12.2 Neurovascular Thrombectomy Device Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Neurovascular Thrombectomy Device Production Mode & Process 12.4 Neurovascular Thrombectomy Device Sales and Marketing 12.4.1 Neurovascular Thrombectomy Device Sales Channels 12.4.2 Neurovascular Thrombectomy Device Distributors 12.5 Neurovascular Thrombectomy Device Customers13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Neurovascular Thrombectomy Device Industry Trends 13.2 Neurovascular Thrombectomy Device Market Drivers 13.3 Neurovascular Thrombectomy Device Market Challenges 13.4 Neurovascular Thrombectomy Device Market Restraints14 Key Findings in The Global Neurovascular Thrombectomy Device Study15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer